Capital World Investors’s Allogene Therapeutics ALLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.6M | Sell |
11,150,000
-1,115,330
| -9% | -$1.26M | ﹤0.01% | 493 |
|
|
2025
Q1 | $17.9M | Buy |
12,265,330
+5,368,778
| +78% | +$7.84M | ﹤0.01% | 467 |
|
|
2024
Q4 | $14.7M | Hold |
6,896,552
| – | – | ﹤0.01% | 464 |
|
|
2024
Q3 | $19.3M | Hold |
6,896,552
| – | – | ﹤0.01% | 453 |
|
|
2024
Q2 | $16.1M | Buy |
+6,896,552
| New | +$16.1M | ﹤0.01% | 454 |
|
|
2022
Q1 | – | Sell |
-1,300,000
| Closed | -$19.4M | – | 582 |
|
|
2021
Q4 | $19.4M | Sell |
1,300,000
-946,576
| -42% | -$14.1M | ﹤0.01% | 526 |
|
|
2021
Q3 | $57.7M | Sell |
2,246,576
-1
| -0% | -$26 | 0.01% | 426 |
|
|
2021
Q2 | $58.6M | Sell |
2,246,577
-26
| -0% | -$678 | 0.01% | 432 |
|
|
2021
Q1 | $79.3M | Sell |
2,246,603
-125,214
| -5% | -$4.42M | 0.01% | 386 |
|
|
2020
Q4 | $59.9M | Sell |
2,371,817
-293,869
| -11% | -$7.42M | 0.01% | 397 |
|
|
2020
Q3 | $101M | Sell |
2,665,686
-815,438
| -23% | -$30.8M | 0.02% | 334 |
|
|
2020
Q2 | $149M | Buy |
3,481,124
+503,460
| +17% | +$21.6M | 0.04% | 277 |
|
|
2020
Q1 | $57.9M | Hold |
2,977,664
| – | – | 0.02% | 323 |
|
|
2019
Q4 | $77.4M | Sell |
2,977,664
-298,021
| -9% | -$7.74M | 0.02% | 322 |
|
|
2019
Q3 | $89.3M | Buy |
3,275,685
+501,104
| +18% | +$13.7M | 0.02% | 297 |
|
|
2019
Q2 | $74.5M | Buy |
2,774,581
+603,098
| +28% | +$16.2M | 0.02% | 316 |
|
|
2019
Q1 | $62.8M | Hold |
2,171,483
| – | – | 0.02% | 328 |
|
|
2018
Q4 | $58.5M | Buy |
+2,171,483
| New | +$58.5M | 0.02% | 329 |
|